Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
4.370
+0.140 (3.31%)
At close: May 12, 2025, 4:00 PM
4.450
+0.080 (1.83%)
After-hours: May 12, 2025, 4:59 PM EDT
Astria Therapeutics Employees
Astria Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 19 or 32.20% compared to the previous year.
Employees
78
Change (1Y)
19
Growth (1Y)
32.20%
Revenue / Employee
n/a
Profits / Employee
-$1,208,462
Market Cap
246.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATXS News
- 10 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 11 days ago - Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology - Business Wire
- 12 days ago - Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference - Business Wire
- 2 months ago - Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - Business Wire
- 2 months ago - Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference - Business Wire
- 2 months ago - Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business Wire
- 2 months ago - Astria Therapeutics: A High-Conviction Bet On HAE - Seeking Alpha